Skip to content

Sunday, November 15, 2026

Latest:

Incorporating health policy and advocacy in emergency medicine residency
Astrocytes come in specialized types that do different jobs in the brain
VA trial to study effects of GLP-1s for alcohol use disorder among veterans
New treatment reduces heart scarring and abnormal heart rhythms, offering a possibility for future therapies
Testosterone: More than sex, muscle and masculinity

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

chemotherapy-resistant cancer cells

Building technologies to predict response to therapy in pediatric acute myeloid leukemia

October 20, 2026 cancer relapse, chemotherapy-resistant cancer cells, pAML, pediatric acute myeloid leukemia, predict cancer relapse, predicting cancer treatment outcomes, Research

The technologies identified tiny populations of cells in pre-treatment bone marrow that predicted relapse could occur months or years later

From the Labs: Image of the Month

From the Labs: Brown Fat

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951